For patients with severe or persistent GI symptoms, temporary dose reduction or holding the GLP-1 medication (under clinician guidance) may be considered
The development of triple-action peptides, such as Retatrutide, suggests that were moving toward more sophisticated and personalized approaches to metabolic health
Wang Q, Gong Y, He Y, Xin Y, Lv N, Du X, Xu J (2021) Genome engineering of Nannochloropsis with hundred-kilobase fragment deletions by Cas9 cleavages
Semaglutide has a half-life of approximately 7 days, which is why it is dosed weekly
L-carnitine plays a key role in transporting fatty acids into the mitochondria, where they can be burned for energy
Identifying optimal dosing regimens may help resolve the context-dependent duality of GLP-1RAs in certain malignancies